In the current study, we report the first case of a TOR1AIP2::ETV6 fusion in a patient with AML that progressed from MDS using targeted RNA-seq, underlining its application in the identification of minor chromosomal variations with elevated sensitivity in spite of the karyotype analysis showing a normal karyotype. Here, TOR1AIP2 is linked to myelodysplastic syndrome.